Video WK 4 (scene 2)

/in /by

Provide a response 3 discussions prompts that your colleagues provided in their video presentations. You may also provide additional information, alternative points of view, research to support treatment, or patient education strategies you might use with the relevant patient.

Responses exhibit synthesis, critical thinking, and application to practice settings…. Responses provide clear, concise opinions and ideas that are supported by at least two scholarly sources…. Responses demonstrate synthesis and understanding of Learning Objectives…. Communication is professional and respectful to colleagues…. Presenters’ prompts/questions posed in the case presentations are thoroughly addressed…. Responses are effectively written in standard, edited English.

So here are my questions:

1. what would be your primary diagnosis is

2. would Wellbutrin be your first choice of antidepressant? If not, why?

3. would you give a prn Vistaril that the pt can take up to 3 times as needed or once daily minimum dose is enough?

Nursing 8-1

/in /by

 Prepare an analysis (5-7 pages) of an adverse event or a near miss from your professional nursing experience and outline a QI initiative that would address it. 

Reply to the following (2) Discussions

/in /by

Please Read the attachment for the instructions

Wk3soap668B

/in /by

Week 3: Problem-Focused SOAP Note

Criteria Ratings Pts

This criterion is linked to a
Learning Outcomes
(Subjective)

2.5 pts

Accomplished

Symptom analysis is well organized, with C/C,

OLD CART, pertinent negatives, and pertinent

positives. All data needed to support the

diagnosis & differential are present. Is

complete, concise, and relevant with no

extraneous data.

2.5 pts

This criterion is linked to a
Learning Outcome
(Objective)

2.5 pts

Accomplished

Complete, concise, well organized, well

written, and includes pertinent positive and

pertinent negative physical findings. Organized

by body system in list format. No extraneous

data.

2.5 pts

This criterion is linked to a
Learning Outcome A
(Assessment)

2.5 pts

Accomplished

Diagnosis and differential dx are correct,

include ICD code, and are supported by

subjective and objective data.

2.5 pts

This criterion is linked to a
Learning Outcome (Plan)

2.5 pts

Accomplished

The plan is organized, complete and supported

with 2 evidence-based references. Addresses

each diagnosis and is individualized to the

specific patient and includes medication

teaching and all 5 components: (Dx plan, Tx

plan, patient education, referral/follow-up,

health maintenance).

2.5 pts

Total Points: 10

Use the template that I gave you before. The first page needs blank for cover sheet.

Diagnoses is R300; Dysuria. Needs ICD 10 codes for differential dx,

CPT codes for labs and procedures such as UA, Urine culture and sensitivity, physical

examination etc Do not paste and copy all (it needs paraphrasing). Research a lot for

patient education, pertinent positive and pertinent negative, non-pharmacologic

treatment etc. APA 7 format. I can give you five days to complete it.

Patient initial: J. V.

Patient DOB: 1963 Sex: F

SUBJECTIVE:

Chief Complaint:

History Of Present Illness:

-Patient is seen today for flank pain and dysuria

Medical History:

COVID pos 5/7/22

anemia

UTI, pyelonephritis s/p hospitalization w/sepsis

Mx kidney stones

Varicose Veis

Scoliosis

Surgical History:

Lithotripsy 2020

Gynecological History:

G5P5A0

denies h/o abnormal pap or mammo

Family History:

M: dementia, lupus, hypothyroid

F: varicose veins

Social History:

-single

-lives with children

-works as food service worker HMH

-denies tobacco

-denies ETOH

-denies recreational drugs

Smoking Status: Never Smoked

Allergies:

Macrobid; ; Dizziness

Morphine; ;

Current Medications:

Currently not taking medications

Review of System:

Constitutional: #fatigue#

Patients deny weight change, fever, chills, weakness, sleep changes, appetite changes.

Head: Patient denies headache.

Neck: Patient denies abnormal masses, neck stiffness.

Eyes: Patient denies vision loss, blurring, discharge, excessive tearing, dryness.

Ears: Patient denies hearing loss, tinnitus, vertigo, discharge, pain

Nose: Patient denies rhinorrhea, stuffiness, sneezing, itching.

Mouth: Patient denies ulcers, bleeding gums, taste problems.

Throat: Patient denies throat pain, difficulty swallowing,

Cardiovascular: Patient denies chest pain, chest pressure, palpitations, DOE,

orthopnea.

Respiratory: Patient denies shortness of breath, cough, increased sputum, hemoptysis.

Gastrointestinal: Patient denies nausea, vomiting, heartburn, dysphagia, diarrhea,

constipation, melena, abdominal pain, jaundice, hemorrhoids.

Genitourinary: #R flank pain, dysuria, increased frequency#

Patient denies abnormal urgency, hesitancy, incontinence, hematuria, nocturia, stones.

Musculoskeletal: Patient denies arthralgias, joint stiffness, myalgias, muscle weakness,

instability and abnormal range of motion

Integumentary (Skin and/or Breast): Patient denies rash, changes in hair, changes in

nail, pruritus

Neurological: Patient denies headache, syncope, seizures, vertigo, ataxia, diplopia,

tremor, numbness, tingling.

Psychiatric: #insomnia#

Patient denies depression, mood abnormalities, anxiety, memory loss, appetite

changes

Endocrine: Patient denies sensitivity to cold or heat, polyuria, polydipsia.

Hematologic/Lymphatic: Patient denies bleeding, bruising, lymphadenopathy.

GYN: Patient denies abnormal bleeding, changes in menstrual cycle, hot flashes.

OBJECTIVE:

Vital Signs:

Height: 64.50 in

Weight: 139.40 lbs

BMI: 23.56

Blood Pressure: 135/78 mmHg

Temperature: 98.60 F

Pulse: 86 beats/min

Physical Exam:

Constitutional:

WD, WN, Alert, Oriented X3 in NAD. Affect appropriate. Gait normal.

Eye: PERRLA, EOMI, nl conjunctiva

Ear: No pinnea/tragal tenderness. Drums are visualized, no wax in canals

Nose: N1 mucosa. N1 Nasal septal walls and turbinates.

Mouth: N1 bucal mucosa, no lesions noted.

Throat: Clear, no erythema or exudates.

Neck: supple, no masses. No thyromegaly. Trachea is midline. N1 carotid auscultation.

No JVD

Cardiovascular: RRR, N1 S1 and S2, No cardiac murmurs, rubs or gallops.

Lungs: ctab, no wheezes, rhonchi or crackles

Chest/Breasts: 4/12/22: #L breast 3 o clock lumpiness, ttp#

Gastrointestinal (Abdomen): soft, nt, nd, bs(+). No palpable masses.

Genitourinary: #R flank CVAT#

Lymphatic: -No LAN noted

Musculoskeletal: #ttp over medial aspect of L knee with preserved ROM with small

healed 1 x1 cm scar from abrasion#

strength symmetrical and wnl. No muscle weakness or stiffness. No joint effusion

Skin: #callus noted between 4th and 5th metatarsal on L foot#

Normal color and texture.

Extremities: #varicose veins R greater than L#

Warm, no clubbing, cyanosis or edema. N1 DP/PT pulses bilaterally

Neurological/Psychiatric: CN I-XII intact, neurosensory wnl, strength (5/5), (2+) DTR

UE/LE bilaterally

-Judgment and insight intact

Imaging: 9/21/22 arterial u/s neg

ASSESSMENT:

Diagnosis:

ICD-10 Codes:

1)M545; Low back pain

2)R300; Dysuria

3)R946; THYROID ABNORMAL RESULT

4)D649; Anemia, unspecified

5)R5383; Fatigue

PLAN:

Procedures:

1) 99215; Comprehensive

2) 99401; 15 min

3) 99000; Handling of specimen from doctor to lab

4) 81002; Urinalysis/Dip

Orders:

1) 5463; UA complete (lab order)

2) 395; UCX (lab order)

Medications:

Augmentin 500-125 MG Oral Tablet; Take 1 tablet orally every 12 hours; Qty: 14;

Refills: 0

Care Plan:

.

***recurrent UTI, h/o pyelo and sepsis- last UCx 4/12/22 showed 100K E coli resistant to

cipro and levaquin. Pt reports 2 day h/o R flank pain, dysuria, frequency and fatigue.

Tried Macrobid in the past which caused severe dizziness.

-UA 12/23/22 pos for leukocytes

-send out Ucx 12/23/22

-Rx Augmentin 500/125mg bid x7 days, r/b d/w pt

-ER precautions over holiday weekend

-referred to uro given recurrent UTI and high-risk history

***abnormal TSH- noted on labs 4/19/22. TSH 0.266 unsure if ever discuss

-reordered TSH 12/23/22

**fatigue- h/o anemia. pt reports hgb dropped to 9 once, donates blood occasionally. per

pt took iron in the past. no overt bleeding 4/19/22 cbc and irons normal. Pt requesting

again to check

-ordered iron panel, ferritin 12/23/22 per pt request

***elevated B12- 4/19/22 B12 level over 1500

-discuss nv, but will need to stop any supplementation

***L knee pain- fell and landed on L knee. worsen with prolonged standing. Reports she

had same pain on R knee and had steriod injection, which resolved it. On PEX, ttp over

medial aspect of L knee with preserved ROM with small healed 1 x1 cm scar.

-on 8/8/22 spoke to pt regrading her L knee x ray. MRI is recommended given that she

sustained a trauma to her knee and has radiologic findings of possible soft tissue injury.

She is in significant pain, takes Ibuprofen, reports difficulty with ambulation. Pt states

that she tried to make appt with ortho and radiology, but no slots were available anytime

soon.

-Needs MRI. Can either order or she can see ortho and do it with them. I was able to

arrange an appt for her to see Dr Panosyan tomorrow at 1:30.

***varicose veins, bil leg pain- to b/l LEX, R greater than L, chronic. c/o occasional

aching. prolonged standing and walking at work. 9/21/22 arterial duplex neg

-Ordered venous u/s 8/3/22

-referred to vein specialist 4/12/22 and 8/3/23

Plan Notes Continued: .

***Tinea cruris bilaterally – noted on PEX on 10/26/22

-Rx ketoconazole 2% cream top bid x 2wks, r/b, d/w pt

***Callus- Pt reports painful, itchy lesion in between 4th and 5th metatarsal. Works long

hours on her feet. Pt reports she has new shoes and tried OTC counter products with

no relief. Admits to trying her son's salicylic acid acne med on lesion. On PEX, small,

hardened callus is noted.

-Referred to podiatry on 10/26/22

***insomnia- chronic. has failed melatonin and hydroxyzine 50 mg. also took Ambien

5mg prn in past

-cont w/caution

Patient Instructions: .

-Pt has been instructed to take medications as prescribed

-Pt received education on compliance with medications and recommendations

-Pt received counseling regarding Medication Side Effects

-Pt received counseling on following a well-balanced healthy diet with veg, fruit and

fiber.

-Pt was instructed to do CV exercise at least 3-4 times every week for 30 minutes.

-Pt received counseling regarding stress management

PHCM: .

58 yo F:

-annual PEX: done 4/12/22–next due 4/12/23

-annual labs: done 4/19/22 unsure if ever discussed

-cervical CA screening: referred to gyn 4/12/22

-breast CA screening: dx mammo L breast u/s ordered 4/12/22

-colon CA screening: referred to GI 4/12/22

-skin CA screening: referred to derm 4/12/22

Immunizations:

-influenza: fall 2021

-tetanus: unsure, rec 4/12/22

-shingrix: rec 4/12/22

-COVID: Pfizer 5/2021, 6/2021, booster 3/2022

  • Week 3: Problem-Focused SOAP Note

SHORT ANSWER

/in /by

Address the following Short Answer prompts for your Assignment. Be sure to include references to the Learning Resources for this week.

  1. In 3 or 4 sentences, explain the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse. Which drugs are contraindicated, if any, and why? Be specific. What is the timeframe that the patient should see resolution of symptoms?
  2. List 4 predictors of late onset generalized anxiety disorder.
  3. List 4 potential neurobiology causes of psychotic major depression.
  4. An episode of major depression is defined as a period of time lasting at least 2 weeks. List at least 5 symptoms required for the episode to occur. Be specific.
  5. List 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia. Be specific. 

Unit 9 peer response. ADHD Medications. 800W. APA. 4 references due 10-30-23

/in /by

Advanced Psychopharmacology and Health Promotion

Unit 9 peer response. ADHD Medications. 800W. APA. 4 references due 10-30-23.

Instructions:

Please read and respond to at least two of your peers' initial postings. You may want to consider the following questions in your responses to your peers:

· Compare and contrast your initial posting with those of your peers.  

· How are they similar or how are they different?

· What information can you add that would help support the responses of your peers?

· Ask your peers a question for clarification about their post.

· What most interests you about their responses? 

Please be sure to validate your opinions and ideas with citations and references in APA format.


Mihaela

Unit 9 – ADHD Medications

1.
What screening tools can be used to affirm your initial diagnosis that Mr. Deliver meets the criteria for ADHD?

One commonly used screening tool is the Adult ADHD Self-Report Scale (ASRS). The ASRS consists of a series of questions that evaluate both inattentive and hyperactive-impulsive symptoms (Anbarasan et al., 2020). Another useful screening tool is the Conners' Adult ADHD Rating Scales (CAARS), which assesses various domains affected by ADHD, such as attention problems, hyperactivity/impulsivity, and executive functioning (Smyth et al., 2019).

2.
Further assessment determines that Mr. Deliver does meet the criteria for ADHD, inattentive type. What is the current recommendation for pharmacological treatment for Mr. Deliver?

Once it is confirmed through further assessment that Mr. Deliver meets the criteria for ADHD, inattentive type, the current recommendation for pharmacological treatment would typically involve stimulant medications such as methylphenidate or amphetamine derivatives. These medications have consistently shown efficacy in improving attention, reducing impulsivity, and enhancing executive functions in adults with ADHD (Farhat et al., 2022). Non-stimulant options like atomoxetine or viloxazine (norepinephrine modulator) may also be considered if there are contraindications or intolerance to stimulants (Mechler et al., 2022). However, considering Mr. Deliver's concerns about stigma and psychotropic medications' risks, it may be worth discussing non-pharmacological interventions as well. Cognitive-behavioral therapy (CBT) has demonstrated efficacy in managing symptoms of adult ADHD. CBT can help Mr. Deliver develop strategies to improve organization skills, time management, and enhance his ability to focus on tasks (Young et al., 2020).

3.
Assume that instead of Mr. Deliver being 36 years old, Thomas is a 13-year-old male that also meets the diagnostic criteria for ADHD, hyperactive type (Thomas is not on any medications at this age). How will your pharmacological treatment change?

In the case of Thomas, a 13-year-old boy diagnosed with ADHD hyperactive type who is not currently taking any medications, the most probable treatment approach would involve the use of stimulant medications. According to the American Academy of Pediatrics (AAP), stimulant medications like methylphenidate are recommended as first-line treatment options for children and adolescents with ADHD, as they have been shown effective in reducing symptoms and improving functioning (Shrestha et al., 2020). However it is important to monitor growth and potential side effects in pediatric patients (Vertessen et al., 2023).

References

Anbarasan, D., Kitchin, M., & Adler, L. A. (2020). Screening for adult adhd. 
Current Psychiatry Reports, 
22(12). 

https://doi.org/10.1007/s11920-020-01194-9Links to an external site.

Farhat, L. C., Flores, J. M., Behling, E., Avila-Quintero, V. J., Lombroso, A., Cortese, S., Polanczyk, G. V., & Bloch, M. H. (2022). The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: A meta-analysis. 
Molecular Psychiatry, 
27(3), 1562–1572. 

https://doi.org/10.1038/s41380-021-01391-9Links to an external site.

Mechler, K., Banaschewski, T., Hohmann, S., & Häge, A. (2022). Evidence-based pharmacological treatment options for adhd in children and adolescents. 
Pharmacology & Therapeutics, 
230, 107940. 

https://doi.org/10.1016/j.pharmthera.2021.107940Links to an external site.

Shrestha, M., Lautenschleger, J., & Soares, N. (2020). Non-pharmacologic management of attention-deficit/hyperactivity disorder in children and adolescents: A review. 
Translational Pediatrics, 
9(S1), S114–S124. 

https://doi.org/10.21037/tp.2019.10.01Links to an external site.

Smyth, A. C., & Meier, S. T. (2016). Evaluating the psychometric properties of the conners adult adhd rating scales. 
Journal of Attention Disorders, 
23(10), 1111–1118. 

https://doi.org/10.1177/1087054715624230Links to an external site.

Vertessen, K., Luman, M., Swanson, J. M., Bottelier, M., Stoffelsen, R., Bet, P., Wisse, A., Twisk, J. R., & Oosterlaan, J. (2023). Methylphenidate dose–response in children with adhd: Evidence from a double-blind, randomized placebo-controlled titration trial. 
European Child & Adolescent Psychiatry. 

https://doi.org/10.1007/s00787-023-02176-xLinks to an external site.

Young, Z., Moghaddam, N., & Tickle, A. (2016). The efficacy of cognitive behavioral therapy for adults with adhd: A systematic review and meta-analysis of randomized controlled trials. 
Journal of Attention Disorders, 
24(6), 875–888. 

https://doi.org/10.1177/1087054716664413Links to an external site.


Ruth

Unit 9: Initial Discussion ADHD Medications

What screening tools can be used to affirm your initial diagnosis that Mr. Deliver meets the criteria for ADHD?

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neuropsychiatric disorder of childhood, with impairing symptoms persisting into adulthood in approximately 70% of cases. Several screening tools are available to help providers identify and diagnose ADHD. The World Health Organization (WHO) Adult ADHD Self-Report Scale Part A is the most commonly used screening tool for ADHD cases in adults. The tool is available in national and international ADHD guidelines.  The screening tool contains six questions that cover inattentive and hyperactive-impulsive symptoms. It also includes a threshold of four or more, which is used for probable ADHD.  The score is calculated according to the number of questions that meet the criteria: sometimes endorsing/often/very often for questions 1–3 and endorsing usually/very often for questions 4–6. However, this screening, even if the patient is positive, may not have an active diagnosis of ADHD; further evaluation is required to ensure symptoms are related to ADHD diagnosis (Chamberlain et al., 2021). 

Further assessment determines that Mr. Deliver does meet the criteria for ADHD, inattentive type. What is the current recommendation for pharmacological treatment for Mr. Deliver?

According to his age and diagnosis, the current recommendation for this patient will be amphetamine 12.5 mg daily. Recommend that the patient start CBT and encourage exercise. A study showed that ADHD drugs are more effective and tolerated by children and adolescents than adults; the reason for this discrepancy is unknown. Amphetamines, methylphenidate, atomoxetine, and modafinil cause weight loss in children, adolescents, and adults. Amphetamines and atomoxetine increased blood pressure in children and adolescents, and methylphenidate increased blood pressure in adults. Methylphenidate showed better symptom control with the most minor side effects for children and adolescents, and amphetamines produced the best results for adults (Gupta, 2018). 

Reference:

Chamberlain, S. R., Cortese, S., & Grant, J. E. (2021). Screening for adult ADHD using brief rating tools: What can we conclude from a positive screen? Some caveats. 
Comprehensive Psychiatry, 
106, 152224. https://doi.org/10.1016/j.comppsych.2021.152224

Gupta, S. (2018). Best First-Line ADHD Medications for Children, Adults: Study Results. 
Attitude. https://www.additudemag.com/adhd-drugs-methylphenidate-vs-amphetamine-treatment/

Mayo Clinic. (2023). Amphetamine (Oral Route). 

https://www.mayoclinic.org/drugs-supplements/amphetamine-oral-route/proper-use/drg-20150941Links to an external site.

Power point presentation

/in /by

  

Week 2 – Statistical Significance vs Clinical Significance

Please review the article An Overview of Statistical and Clinical Signficance in Nursing Research 

(listed in week 2) as well a view this week’s recording.  Pair up with another student(s) based on instructor instructions, being assigned a group number. Create a brief PowerPoint (or other approved media) presentation explaining:

Slide 1. The definition of Statistical Significance and Clinical Significance

Slide 2. Explain how they are individually important when looking at research.

Slide 3. Present an example, using referenced literature, of each.

Slide 4. Explain how you will utilize this difference as you review literature.

Please create a link (YouTube, Vimeo, etc) and post this recorded presentation link in the discussion board. Each person from your group needs to post in the discussion board, but the post should be titled “Group#_Significance.”

This discussion board lasts one week. Each student is expected to participating incrafting the initial post in a new thread that refers to relevant course readings, this week’s highlighted article and draws from at least one additional external reference.. Discussion board posts may incorporate personal experiences in addition to course content.

You must have these components covered to earn all points:

1. APA formatting is required

2. At least 3 References.

help

/in /by

Critique a Aanp organization

Write a 2 page critique of this meeting using APA format for any cited resources and create a document that describes: 

  1. The Organization
  2. Mission, goals, and focus
  3. Membership

deductive

/in /by

Module 03 Content

1.

Top of Form

You are a Training Specialist hired by Universal Medical Supplies, Inc. This organization has been experiencing low productivity and errors in communication in the workplace. As part of an ongoing professional development series, the Vice President of the Human Resources department has tasked you with creating Critical Thinking training materials. The materials will be presented in many forms and by various means to help improve productivity and communication in the organization.

For a short training presentation during a regional meeting, you have been asked to create a 3- to 5-minute video presentation illustrating the differences between deductive and inductive argument.

Instructions

Use PowerPoint and a video recording program such as Screencast-O-Matic to create a training video that is 3-5 minutes in length and includes the following elements:

· Bullet points with brief text that outlines deductive reasoning.

· Bullet points with brief text that outlines inductive reasoning.

· Clip art or images to accompany your text. You may use characters, cartoons, drawing tools, or other technologies to be creative.

· Narration related to the bullet points to explain:

· The principles underlying both deductive and inductive reasoning.

· Clear examples of both deductive and inductive reasoning in a workplace setting.

· References to your sources at the end of the video.

Your PowerPoint

Slide 1) Title slide 

Slides 2-3) Deductive reasoning. You’ll want to provide an example or two. Talk about the value of deduction and why it’s useful. 

Slides 4-5) Inductive reasoning. Again, provide an example or two. Discuss the value of induction and how it is used. 

Slide 6) References. Yes, they count.

Bottom of Form

What Sort of Leader Is Needed?

/in /by

 

Case Study

Two new associate-degree graduates were hired for the pediatric unit. Both worked three 12-hour shifts a week; Jan worked the day-to-evening shift and Rosemary worked the night shift. Whenever their shifts connected, they would compare notes on their experience. Jan felt she was learning rapidly, gaining clinical skills and beginning to feel at ease with her colleagues.

Rosemary, however, still felt unsure of herself and often isolated. There have been times that she was the only registered nurse on the unit all night. The aides and LPNs were very experienced, but Rosemary feels she is not ready for that kind of responsibility. Rosemary knows she must speak to the nurse manager about this, but she’s called several times, and she’s never available. The shift assignments are left in the staff lounge by an assistant.

Questions

Your discussion post should answer the following questions in a well-constructed commentary. Use references, in APA format, where appropriate.

  1. To what extent is this problem due to a failure to lead? Who has failed to act?
  2. What style of leadership was displayed by Rosemary? The nurse manager?
  3. How effective was their leadership? What are your suggestions for Rosemary?